Home Other Building Blocks 2-Hydroxy-2-phenylpropanoic acid

2-Hydroxy-2-phenylpropanoic acid

CAS No.:
515-30-0
Catalog Number:
AG003ES1
Molecular Formula:
C9H10O3
Molecular Weight:
166.1739
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$164
- +
5g
98%
In Stock USA
United States
$446
- +
Product Description
Catalog Number:
AG003ES1
Chemical Name:
2-Hydroxy-2-phenylpropanoic acid
CAS Number:
515-30-0
Molecular Formula:
C9H10O3
Molecular Weight:
166.1739
MDL Number:
MFCD00149292
IUPAC Name:
2-hydroxy-2-phenylpropanoic acid
InChI:
InChI=1S/C9H10O3/c1-9(12,8(10)11)7-5-3-2-4-6-7/h2-6,12H,1H3,(H,10,11)
InChI Key:
NWCHELUCVWSRRS-UHFFFAOYSA-N
SMILES:
OC(=O)C(c1ccccc1)(O)C
EC Number:
208-196-1
Properties
Complexity:
173  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
166.063g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
166.176g/mol
Monoisotopic Mass:
166.063g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
57.5A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
1  
Literature
Title Journal
Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approach. Drug metabolism and disposition: the biological fate of chemicals 20111101
Characterization of an unusual adsorption behavior of racemic methyl-mandelate on a tris-(3,5-dimethylphenyl) carbamoyl cellulose chiral stationary phase. Journal of chromatography. A 20110923
A systems biology approach uncovers cellular strategies used by Methylobacterium extorquens AM1 during the switch from multi- to single-carbon growth. PloS one 20100101
Characterization of electroconductive blends of poly(HEMA-co-PEGMA-co-HMMA-co-SPMA) and poly(Py-co-PyBA). Biomacromolecules 20090914
Target selection and annotation for the structural genomics of the amidohydrolase and enolase superfamilies. Journal of structural and functional genomics 20090401
Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results? Annals of clinical biochemistry 20060701
3,4-methylenedioxymethamphetamine (MDMA) intoxication in an infant chronically exposed to cocaine. Therapeutic drug monitoring 20050801
A glycopeptide antibiotic chiral stationary phase for the enantiomer resolution of hydroxy acid derivatives by capillary electrochromatography. Electrophoresis 20030301
Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites. Bioorganic & medicinal chemistry 20020401
Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clinical chemistry 20011001
A novel enantioselective synthetic route to omuralide analogues with the potential for species selectivity in proteasome inhibition. Organic letters 20010503
Sweat testing of MDMA with the Drugwipe analytical device: a controlled study with two volunteers. Journal of analytical toxicology 20010301
Metabolism and disposition of alpha-methylstyrene in rats. Drug metabolism and disposition: the biological fate of chemicals 20010201
Properties